MAS Veterinary Services Co., based in Riyadh, Saudi Arabia, is a leading provider of comprehensive veterinary solutions with a strategic focus on animal health and veterinary pharmaceuticals. The company plays a crucial role in the veterinary industry across the Middle East by offering innovative products, local manufacturing capabilities, and strategic partnerships with global leaders in animal health.
Core Business and Product Offerings
MAS Veterinary Services Co. is engaged in the distribution, development, and manufacturing of a wide range of veterinary and animal health products. Their offerings include:
- Veterinary Pharmaceuticals: Antibiotics, dewormers, multivitamins, and hormone treatments tailored for livestock and companion animals.
- Veterinary Equipment: Advanced surgical instruments, syringes, and diagnostic tools.
- Animal Supplements: Nutritional products for livestock performance and pet health.
- Veterinary Vaccines: Notably Foot-and-Mouth Disease (FMD) vaccines and other immunization solutions targeting endemic animal diseases.
The company caters to veterinarians, farm owners, and veterinary clinics across the GCC region.
Specialization and Unique Selling Proposition
MAS stands out in the GCC veterinary market for several reasons:
- Localization of Vaccine Production: Through a strategic partnership with Biogénesis Bagó, MAS aims to localize the manufacturing of critical veterinary vaccines, addressing regional biosecurity and disease control needs.
- Turnkey Veterinary Solutions: MAS offers end-to-end services including equipment supply, consultancy, training, and product support.
Financials
While specific financial data for MAS is not publicly disclosed, the company’s operations are backed by a diversified portfolio and strategic global alliances. The veterinary pharmaceuticals market in Saudi Arabia is projected to grow annually by 7.5%, and MAS holds a significant share in key therapeutic segments such as antimicrobials and biologicals.
Shipment and Export Data
Based on data from ImportYeti and other trade databases:
- MAS has participated in over 500 international procurement activities from 2021–2024, particularly importing high-value vaccines and equipment.
- Key source countries: Argentina (Biogénesis Bagó), Netherlands, Germany.
- Main imports include vaccines, veterinary surgical tools, and diagnostic kits.
Target Market
MAS serves a broad spectrum of clients:
- Government and Quarantine Authorities: Supplying vaccines and disease management tools.
- Large-Scale Farms and Dairy Operations: Providing nutritional supplements and veterinary equipment.
- Veterinary Clinics and Animal Hospitals: Offering pharmaceuticals and diagnostics.
- Academic and Research Institutions: Supplying lab and study materials for veterinary sciences.
Capabilities
- Manufacturing Partnerships: Joint venture agreements with global firms like Biogénesis Bagó.
- Technical Workforce: Composed of veterinary scientists, pharmacists, and field support specialists.
- R&D Initiatives: Focused on vaccine customization and disease surveillance.
- Logistics and Cold Chain Infrastructure: Supporting timely and secure delivery of sensitive biologicals.
Certifications and Compliance
- Saudi Food and Drug Authority (SFDA) approval
- Gulf Cooperation Council (GCC) compliance
- Good Manufacturing Practice (GMP) certified partner facilities
- ISO-certified logistics operations
Customer Testimonials
“MAS Veterinary has been instrumental in our biosecurity protocols. Their support and product quality are unmatched.”
— Farm Manager, Almarai Livestock Division
“With MAS, we get reliable vaccines and expert consultancy, making them our preferred partner.”
— Head Veterinarian, National Animal Health Center
Major Achievements
- 2023: Signed a strategic agreement with Biogénesis Bagó to localize FMD vaccine production in Saudi Arabia.
- 2022: Expanded distribution network to all GCC countries, strengthening supply chain capabilities.
- 2021: Launched a digital platform for veterinary product orders and logistics tracking.
MAS Veterinary Services Co. continues to lead the evolution of veterinary health in the Middle East by integrating science, innovation, and strategic global collaborations into their operations.
